心血管疾病Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D2/D3 Receptor Antagonist for the Management of Gastroparesis.
期刊:The Journal of pharmacology and experimental therapeutics发表年份:2021作者:Roger L Whiting; Agnes Choppin; Gary Luehr; Jeffrey R Jasper
